CardioPharma Reviews Applications to Explore Non-Cardiovascular Benefits of CVD Polypill

WILMINGTON, N.C., May 12, 2026 /PRNewswire/ -- CardioPharma, Inc., a specialty pharmaceutical company focused on combinatorial drug development for cardiovascular disease, is currently reviewing applications for secondary analyses of existing datasets to investigate the non-cardiovascular...